Skip Navigation

This Article
Right arrow Extract Freely available
Right arrow Print PDF (45K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (99)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Schorpp, M
Right arrow Articles by Angel, P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schorpp, M
Right arrow Articles by Angel, P
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1996 Oxford University Press 1787-1788

Footnote

The human ubiquitin C promoter directs high ubiquitous expression of transgenes in mice

The human ubiquitin C promoter directs high ubiquitous expression of transgenes in mice Marina Schorpp , Richard Jäger 1 , Karl Schellander 2 , Johannes Schenkel 1 , Erwin F. Wagner 2 , Hans Weiher 1 and Peter Angel*

Deutsches Krebsforschungszentrum Heidelberg, Abteilung Signaltransduktion und Wachstumskontrolle, Im Neuenheimer Feld 280, D-69120 Heidelberg , Germany , 1 Forschungszentrum Karlsruhe, Institut für Genetik, Postfach 3640, D-76021 Karlsruhe , Germany and 2 Research Institute of Molecular Pathology (IMP), Dr Bohr-Gasse 7, A-1030 Vienna , Austria

Received January 3, 1996; Revised and Accepted March 19, 1996

Transgenic mice provide one of the best experimental systems to study gene function in vivo . Although transgenic mice carry the additional genetic material in every cell of the body, expression of the transgenes under the control of constitutive promoter/enhancer units, such as the murine major histocompatibility complex promoter H2-K b , the CMV enhancer/promoter, the murine Pgk-1 promoter or the chicken cytoplasmatic [beta] -actin promoter is often restricted to a limited number of tissues ( 1 - 5 ). However, for most experimental dominant gain-of-function approaches addressing the role of a given protein in a multicellular organism an ubiquitous expression of the transgene might be highly desired. Here we report the application of a powerful expression vector using the 5'-flanking region of the human ubiquitin C gene that allows very efficient expression of a given transgene in a broad range of tissues.

The structure of the ubiquitin proteins is highly conserved during evolution. In human, there exist several ubiquitin proteins which are encoded by a multigene family ( 6 ). According to the general requirement of these proteins for ATP-dependent, non-lysosomal intracellular protein degradation ubiquitin proteins have been found in all eukaryotic cells examined so far (for review see 7 , 8 ).

Previous work has demonstrated that the human ubiquitin C promoter is very active in conferring expression of exogenous genes following transient transfection of the appropriate expression vectors in various cell lines ( 9 ; Schorpp and Angel, unpublished). In view of its powerful and ubiquitous activity in tissue culture cells we have used the human ubiquitin C promoter as regulatory unit to drive overexpression of two cellular genes, junB and bcl-2[alpha], in transgenic mice.

As shown in Figure 1 A, Ubi-JunB and Ubi-Bcl-2[alpha] carry 1.2 kb of the human ubiquitin C promoter region (position -1225 to -6) fused to either the coding region of the mouse junB gene (position +240 to +1485; 10 ) or the human bcl-2[alpha] cDNA ( 11 ) respectively. 3' of the coding sequences, 150 bp of 3' nontranslated sequences of the human c-jun gene ( 12 ) and the splice and poly(A) sequences of SV40 were inserted.


Figure 1 . ( A ) The structure of the transgene constructs. Dashed boxes represent the junB cDNA and the bcl-2[alpha] cDNA that have been cloned into the multiple cloning site of the vector (MCS, solid box). The 5' end of either one of the transgene consists of the human ubiquitin C promoter from position -1225 to -6 (9). The 3' end is composed of 150 bp from the human c-jun (12) and SV40 splice and poly(A) sequences. (B and C) Expression of the transgenes in various mouse tissues. ( B ) Transcripts derived from the Ubi-JunB transgene were monitored by RNase protection mapping (12) using a junB-specific antisense RNA probe and 20 [mu]g total RNA from 10 different organs of an adult transgenic mouse (line 1598). The protected fragments specific for the transcript from the transgene (T) as well as from the endogenous gene (E) are indicated by arrows. As a control for the transcripts derived from the Ubi-junB transgene, RNA from F9 cells that had been transiently transfected with either the Ubi-JunB expression vector, or with an empty expression vector (RSV-O) was analyzed in parallel. ( C ) Northern Blot analysis of total RNA from various organs of wild-type or transgenic animals (line 2272) was performed to analyze the expression of the bcl-2[alpha] transgene. Fifteen [mu]g (or 5 [mu]g from skin) total RNA were electrophoresed, blotted and probed for human bcl-2[alpha] expression. The transcripts originated from the transgene are marked by an arrow (T). The endogenous mouse bcl-2[alpha] transcript that crosshybridizes with the human probe is shown as well (E: brain, thymus). Glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) was used as an internal control for the quality of the RNA.

These gene constructs were used to generate four independent Ubi-junB and two bcl-2[alpha] transgenic mouse lines. Two out of four Ubi-junB lines (1598 and 1605) and both bcl-2[alpha] lines (2266 and 2272) showed high level expression of the transgene in all tissues which were examined (Fig. 1 B and C). Efficient expression from the Ubi-JunB construct could be detected at early stages of development (10.5, 11.5, 12.5, 14.5 and 15.5 d.p.c.; data not shown) and in tissues of adult animals (Fig. 1 B). The levels of expression of junB and bcl-2[alpha] transgenes in some tissues were up to 20-fold higher than of the endogenous transcript (e.g. liver and brain, and brain; Fig. 1 B and C respectively). The ubiquitous presence of the bcl-2[alpha] transgene product was also confirmed by western blot analysis (data not shown).

The human ubiquitin C sequences described here allow expression of transgenes in an even wider range of tissues compared to the promoter/enhancer units that are routinely used. Transgenes driven by H2-K b , CMV or Pgk-1 regulatory sequences are highly expressed in spleen, lung and salivary glands (H2-K b ; 1 ), in spleen, stomach and heart (CMV; 2 , 3 ), or in heart, kidney and brain ( Pgk-1 ; 4 ). Only very low expression has been found for each regulatory unit in certain tissues, such as stomach and brain (H2-K b ), liver (CMV and Pgk-1 ) and spleen (Pgk-1) . Most importantly, the human ubiquitin C promoter is able to confer high expression also in those tissues in which the other promoter/enhancer sequences are hardly active. Therefore, the human ubiquitin C 5'-flanking sequences appear to be a powerful transcriptional control unit useful for experiments in which transgene expression in a very broad range of tissues is required.

ACKNOWLEDGEMENTS

We thank Drs L. E. Theill and G. E. Evan for the kind gifts of the ubiquitin C promoter and the bcl-2[alpha] cDNA, respectively. This work was supported by grants from the Deutsche Forschungsgemeinschaft (An 182/6-2, We 970/5) and from the European Economic Community Biomedicine and Health Program.

REFERENCES

1 Rüther, U., Müller, W., Sumida, T., Tokuhisa, T., Rajewski, K. and Wagner, E.F. (1988) Cell 53, 847-856. MEDLINE Abstract

2 Schmidt, E.V., Christoph, G., Zeller, R. and Leder P. (1990) Mol. Cell. Biol. 10, 4406-4411. MEDLINE Abstract

3 Furth, P.A., Hennighausen, L., Baker, C., Beatty, B. and Woychick, R. (1991) Nucleic Acids Res. 19, 6205-6208. MEDLINE Abstract

4 McBurney, M.W., Staines, W,. A., Boekelheide, K., Parry, D., Jardine, K. and Pickavance, L. (1994) Dev. Dynamics 200, 278-293.

5 Sands, A.T., Hansen, T.N., Demayo, F.J., Stanley, L.A., Xin, L. and Schwartz, R.J. (1993) Mol. Reprod. Dev. 34, 117-126. MEDLINE Abstract

6 Wiborg, O., Pedersen, M.S., Wind, A., Berglund, L.E., Marcker, K.A. and Vuust, J. (1985) EMBO J. 4, 755-759. MEDLINE Abstract

7 Hershko, A. and Ciechanover, A. (1982) Annu. Rev. Biochem. 51, 335-364. MEDLINE Abstract

8 Ciechanover, A. Finley, D. and Varshavsky, A. (1984) J. Cell Biochem. 24, 27-53. MEDLINE Abstract

9 Schjellerup Wulff, B., O'Hare, M.M.T., Boel, E., Theill, L.E. and Schwartz, T.W. (1990) FEBS Lett. 261, 101-105. MEDLINE Abstract

Ryder, K., Lau, L. and Nathans, D. (1988) Proc. Natl Acad. Sci. USA 85 , 1487-1491.

11 Fanidi, A., Harrington, E.A. and Evan, G.I. (1992) Nature 359, 554-556. MEDLINE Abstract

12 Angel, P., Hattori, K., Smeal, T. and Karin, M. (1988) Cell 55, 875-885. MEDLINE Abstract


Return

* To whom correspondence should be addressed
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
T. Ota, M. Aoki-Ota, B. H. Duong, and D. Nemazee
Suppression of IgE B Cells and IgE Binding to Fc{epsilon}RI by Gene Therapy with Single-Chain Anti-IgE
J. Immunol., June 15, 2009; 182(12): 8110 - 8117.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Watanabe, M. J. Smith, E. Heilig, V. Beglopoulos, R. J. Kelleher III, and J. Shen
Indirect Regulation of Presenilins in CREB-mediated Transcription
J. Biol. Chem., May 15, 2009; 284(20): 13705 - 13713.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. H. Reyes, K. S. O'Shea, N. L. Wys, J. M. Velkey, D. M. Prieskorn, K. Wesolowski, J. M. Miller, and R. A. Altschuler
Glutamatergic Neuronal Differentiation of Mouse Embryonic Stem Cells after Transient Expression of Neurogenin 1 and Treatment with BDNF and GDNF: In Vitro and In Vivo Studies
J. Neurosci., November 26, 2008; 28(48): 12622 - 12631.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. Baumel, A. Lechner, T. Hehlgans, and D. N. Mannel
Enhanced susceptibility to Con A-induced liver injury in mice transgenic for the intracellular isoform of human TNF receptor type 2
J. Leukoc. Biol., July 1, 2008; 84(1): 162 - 169.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Klucky, R. Mueller, I. Vogt, S. Teurich, B. Hartenstein, K. Breuhahn, C. Flechtenmacher, P. Angel, and J. Hess
Kallikrein 6 Induces E-Cadherin Shedding and Promotes Cell Proliferation, Migration, and Invasion
Cancer Res., September 1, 2007; 67(17): 8198 - 8206.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
P. Soulas-Sprauel, G. Le Guyader, P. Rivera-Munoz, V. Abramowski, C. Olivier-Martin, C. Goujet-Zalc, P. Charneau, and J.-P. de Villartay
Role for DNA repair factor XRCC4 in immunoglobulin class switch recombination
J. Exp. Med., July 9, 2007; 204(7): 1717 - 1727.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
P.-O. Angrand, I. Segura, P. Volkel, S. Ghidelli, R. Terry, M. Brajenovic, K. Vintersten, R. Klein, G. Superti-Furga, G. Drewes, et al.
Transgenic Mouse Proteomics Identifies New 14-3-3-associated Proteins Involved in Cytoskeletal Rearrangements and Cell Signaling
Mol. Cell. Proteomics, December 1, 2006; 5(12): 2211 - 2227.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. T. Dann, A. L. Alvarado, R. E. Hammer, and D. L. Garbers
Heritable and stable gene knockdown in rats
PNAS, July 25, 2006; 103(30): 11246 - 11251.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
D. E. Fedele, N. Gouder, M. Guttinger, L. Gabernet, L. Scheurer, T. Rulicke, F. Crestani, and D. Boison
Astrogliosis in epilepsy leads to overexpression of adenosine kinase, resulting in seizure aggravation
Brain, October 1, 2005; 128(10): 2383 - 2395.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
D. Ait-Azzouzene, L. Verkoczy, J. Peters, A. Gavin, P. Skog, J. L. Vela, and D. Nemazee
An immunoglobulin C{kappa}-reactive single chain antibody fusion protein induces tolerance through receptor editing in a normal polyclonal immune system
J. Exp. Med., March 7, 2005; 201(5): 817 - 828.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
O. Kassel, S. Schneider, C. Heilbock, M. Litfin, M. Gottlicher, and P. Herrlich
A nuclear isoform of the focal adhesion LIM-domain protein Trip6 integrates activating and repressing signals at AP-1- and NF-{kappa}B-regulated promoters
Genes & Dev., October 15, 2004; 18(20): 2518 - 2528.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Y. J. Chiang, M. T. Hemann, K. S. Hathcock, L. Tessarollo, L. Feigenbaum, W. C. Hahn, and R. J. Hodes
Expression of Telomerase RNA Template, but Not Telomerase Reverse Transcriptase, Is Limiting for Telomere Length Maintenance In Vivo
Mol. Cell. Biol., August 15, 2004; 24(16): 7024 - 7031.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
L. Kenner, A. Hoebertz, T. Beil, N. Keon, F. Karreth, R. Eferl, H. Scheuch, A. Szremska, M. Amling, M. Schorpp-Kistner, et al.
Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects
J. Cell Biol., February 16, 2004; 164(4): 613 - 623.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Matsuda and C. L. Cepko
Inaugural Article: Electroporation and RNA interference in the rodent retina in vivo and in vitro
PNAS, January 6, 2004; 101(1): 16 - 22.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. P. Szremska, L. Kenner, E. Weisz, R. G. Ott, E. Passegue, M. Artwohl, M. Freissmuth, R. Stoxreiter, H.-C. Theussl, S. B. Parzer, et al.
JunB inhibits proliferation and transformation in B-lymphoid cells
Blood, December 1, 2003; 102(12): 4159 - 4165.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M.-Y. Yang, T.-C. Liu, J.-G. Chang, P.-M. Lin, and S.-F. Lin
JunB gene expression is inactivated by methylation in chronic myeloid leukemia
Blood, April 15, 2003; 101(8): 3205 - 3211.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. P. M. Reddy and B. T. Mossman
Role and regulation of activator protein-1 in toxicant-induced responses of the lung
Am J Physiol Lung Cell Mol Physiol, December 1, 2002; 283(6): L1161 - L1178.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
X. Li, A. Warri, S. Makela, T. Ahonen, T. Streng, R. Santti, and M. Poutanen
Mammary Gland Development in Transgenic Male Mice Expressing Human P450 Aromatase
Endocrinology, October 1, 2002; 143(10): 4074 - 4083.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. B. Rulli, A. Kuorelahti, O. Karaer, L. J. Pelliniemi, M. Poutanen, and I. Huhtaniemi
Reproductive Disturbances, Pituitary Lactotrope Adenomas, and Mammary Gland Tumors in Transgenic Female Mice Producing High Levels of Human Chorionic Gonadotropin
Endocrinology, October 1, 2002; 143(10): 4084 - 4095.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Andrecht, A. Kolbus, B. Hartenstein, P. Angel, and M. Schorpp-Kistner
Cell Cycle Promoting Activity of JunB through Cyclin A Activation
J. Biol. Chem., September 20, 2002; 277(39): 35961 - 35968.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
B. T. Kile, D. Metcalf, S. Mifsud, L. DiRago, N. A. Nicola, D. J. Hilton, and W. S. Alexander
Functional Analysis of Asb-1 Using Genetic Modification in Mice
Mol. Cell. Biol., September 15, 2001; 21(18): 6189 - 6197.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Tallone, S. Malin, A. Samuelsson, J. Wilbertz, M. Miyahara, K. Okamoto, L. Poellinger, L. Philipson, and S. Pettersson
A mouse model for adenovirus gene delivery
PNAS, July 3, 2001; 98(14): 7910 - 7915.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
X. Li, E. Nokkala, W. Yan, T. Streng, N. Saarinen, A. Warri, I. Huhtaniemi, R. Santti, S. Makela, and M. Poutanen
Altered Structure and Function of Reproductive Organs in Transgenic Male Mice Overexpressing Human Aromatase
Endocrinology, June 1, 2001; 142(6): 2435 - 2442.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
M Schreiber, Z. Wang, W Jochum, I Fetka, C Elliott, and E. Wagner
Placental vascularisation requires the AP-1 component fra1
Development, January 11, 2000; 127(22): 4937 - 4948.
[Abstract] [PDF]


Home page
ScienceHome page
C. Lois, E. J. Hong, S. Pease, E. J. Brown, and D. Baltimore
Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors
Science, February 1, 2002; 295(5556): 868 - 872.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Y. Wan, R. P. Leon, R. Marks, C. M. Cham, J. Schaack, T. F. Gajewski, and J. DeGregori
Transgenic expression of the coxsackie/adenovirus receptor enables adenoviral-mediated gene delivery in naive T cells
PNAS, December 5, 2000; 97(25): 13784 - 13789.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Extract Freely available
Right arrow Print PDF (45K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (99)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Schorpp, M
Right arrow Articles by Angel, P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schorpp, M
Right arrow Articles by Angel, P
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?